Our lawyers are handling Camp Lejeune bladder cancer lawsuits in all 50 states.
This page is about bladder cancer injury and wrongful death claims. Our law firm discusses the legislation that will allow a Camp Lejeune water contamination lawsuit.
Our lawyers also speculate on the potential settlement amounts of bladder cancer victims and wrongful death survivors might recover in these lawsuits.
Camp Lejeune Class Action Lawsuit
From the early 1950s to the late 1980s, the drinking water supply at U.S. Marine Corps Base Camp Lejeune was severely contaminated with carcinogenic chemicals. Public health studies on the impact of this contamination have concluded that exposure to the Camp Lejeune water caused increased rates of specific types of cancer. One of the cancer types with the strongest link to the Lejeune water supply is bladder cancer.
Thousands of former residents and employees of Camp Lejeune have developed bladder cancer as a result of the chemicals in the water supply. These victims have previously been barred from pursuing personal injury claims.
Today, however, the 117th Congress is very close to enacting a new law that will give victims of the Camp Lejeune water contamination a special right to bring negligence claims against the government and get compensation.
Short Review of Camp Lejeune Water Pollution
Since the early 1940s, Camp Lejeune has been one of the biggest and most active Marine Corps bases in the United States. Encompassing over 150,000 acres and 11 miles of shoreline on the south coast of North Carolina, Camp Lejeune is the biggest USMC base on the east coast and ranks behind Camp Pendleton in San Diego as the largest USMC base in the U.S.
Like most Marine Corps bases, Camp Lejeune is like a mid-sized town with a population of around 50,000. This population includes Marines and their families living in on-base housing units and serviced by schools, hospitals, and other facilities. Since the base opened, Camp Lejeune has operated its water supply system using a series of massive groundwater wells.
In the late 1980s, it was discovered that the water supply at Camp Lejeune was critically contaminated with industrial chemicals. The primary toxins in the Lejeune water were 2 industrial solvents perchloroethylene (PCE) and trichloroethylene (TCE).
Later research revealed that the Camp Lejeune water supply had been contaminated with these chemicals from August 1953 to December 1987. The extent and level of contamination were unprecedented with TCE and PCE being found at several thousand times the maximum safe limits.
Bladder cancer is the fifth most common human malignancy and the second most frequently diagnosed genitourinary tumor after prostate cancer. It is the fourth most common cancer in men, but it’s less common in women. The American Cancer Society estimates that in the United States there will be 81,180 new cases of bladder cancer diagnosed in 2022 (about 61,700 men and 1480 in women) and about 17,100 deaths from bladder cancer (about 12,120 in men and 4,980 in women).
The severity of bladder cancer is described in the same progressive categories you see with other types of cancer:
- State 0: abnormal cells on the inner lining of the bladder
- Stage I: disease spreads to the tissue layer adjacent to the inner lining of the bladder
- Stage II: cancer invades muscle tissue
- Stage III: spreads to the fatty tissue around the bladder and/or reproductive organs
- Stage IV: bladder cancer has reached the abdominal wall, the pelvis, or the lymph nodes.
There are many contributing factors to bladder cancer. We have long known that contaminated well water can cause bladder cancer.
Is Bladder Cancer Linked to Camp Lejeune Water Contamination?
Yes. Bladder cancer is one of the cancer types that has the strongest link to the contaminated Camp Lejeune toxic water. About a dozen other types of cancer have also been linked including kidney and lung cancer.
Evidence Linking Bladder Cancer to Camp Lejeune Water
The water contamination at Camp Lejeune and the USMC’s mishandling of it prompted public anger. This motivated the federal government to fund numerous scientific studies to evaluate the impact that the contaminated water had on the health of the people who lived and worked at Camp Lejeune.
The Agency for Toxic Substances and Disease Registry (ATSDR) is an investigative branch of the Centers for Disease Control (CDC). The ATSDR has been conducting extensive research and studies on the Camp Lejeune water disaster for 3 decades.
In 2014, an ATSDR Morbidity Study was published which detailed the results of a large-scale study into the health impact of the contaminated water at Camp Lejeune. The ATSDR Morbidity Study looked at health records for military personnel, their families, and civilian employees at Camp Lejeune during the time that the water was polluted. These records were compared to a control group from another USMC base (Camp Pendleton) where the water was not contaminated.
The ATSDR Morbidity Study concluded that the contaminated drinking water at Camp Lejeune was linked to an increased risk of bladder cancer. The study showed that former residents and employees at Lejeune who were exposed to TCE and/or PCE in the water supply displayed significantly higher rates of bladder cancer. This finding makes intuitive sense given that the bladder is the organ with the most significant interaction with drinking water.
In 2012, the Environmental Protection Agency (EPA) published toxicologic reviews on TCE and PCE which found that both chemicals were carcinogenic to humans. A similar conclusion was reached by the International Agency for Research on Cancer (IARC) the following year. These conclusions were based largely on specific epidemiologic studies showing a clear association between PCE and bladder cancer.
Camp Lejeune Bladder Cancer Lawsuits Under New Federal Law
Victims of the Camp Lejeune water contamination have never been able to get the justice they deserve. All previous civil lawsuits have been effectively blocked by a strict law in North Carolina. Now, however, Congress is about to fix this with the passage of new federal law that will permit Lejeune victims to bring civil claims.
Camp Lejeune Justice Act of 2022
The Camp Lejeune Justice Act (CLJA), (which is now part of a larger bill called the PACT Act), passed the House of Representatives in March by a vote of 256 to 174. On June 16, 2022, the Senate passed the PACT Act by a vote of 84-14. The Senate version of the bill included several amendments that required approval by the House. There is no doubt that the bill is eventually going to pass.
CLJA Is Unique Legislation
The Camp Lejeune Justice Act provides for an uncommon carve-out that allows the military to bring file a Camp Lejeune Lawsuit against the government. This new law to protect veterans’ rights is an uncommon departure from the long-standing ban on personal injury and wrongful death lawsuits against the U.S. government by service members that relates to military matter. This law creates an exception to this law that was created by the United States Supreme Court in Feres v United States, 340 U.S. 135 (1950).
Legislation Will Allow for Camp Lejeune Bladder Cancer Lawsuits
When the CLJA/ACT Act is eventually passed, Camp Lejeune water victims will have the right to bring civil negligence claims against the federal government for injuries caused by the contaminated water. Claimants under the CLJA will still have the burden of proving their claims, but the CLJA has created a new, lowered standard of proof for establishing causation.
Under the CLJA, claimants can establish causation based on a single, valid, scientific study linking their alleged injuries to Camp Lejeune’s water. In the case of bladder cancer, several accepted studies (including the ATSDR study) have verified the link between bladder cancer and the Camp Lejeune water.
About Bladder Cancer
Bladder cancer or cancer originating in the bladder is the Sixth most frequently diagnosed cancer type in the U.S. About 81,000 new cases of bladder cancer are diagnosed each year and 17,000 people die from bladder cancer annually.
Bladder cancer disproportionately occurs in men. Of the roughly 81,000 bladder cancer cases diagnosed each year, 62,000 occur in men compared to only 19,000 in women. This means men are 3-4 times more likely to get bladder cancer compared to women.
Bladder cancer is often diagnosed fairly early. Around 50% of all bladder cancer cases are diagnosed in the early stages and only 4% of cases are diagnosed after Stage III. The overall 5-year survival rate for bladder cancer (all stages) is 77%.
Camp Lejeune Bladder Cancer Settlement Amounts
It would be very premature right now to claim with any certainty what the settlement value of Camp Lejeune bladder cancer claims will be. So, while we make Camp Lejeune bladder cancer settlement amount estimates here, you need to take them with many grains of salt.
Still, Camp Lejeune victims want an estimate of the potential settlement amount of their lawsuit. Because a civil lawsuit is about money in either a settlement or jury payout. So we do this based on verdicts and reported settlements in prior cases involving bladder cancer (mostly failure to diagnose malpractice cases).
What Is Expected Settlement Payout for a Camp Lejeune Bladder Cancer Lawsuit?
Based on these prior data points and the expected settlement amounts for Camp Lejeune lawsuits generally, our attorneys estimate that Camp Lejeune claims involving bladder cancer will have an average per person settlement payout range of $145,000 to $220,000.
The factors that would impact the settlement value of individual claims include the age of the victim, stage of cancer, the extent of exposure to Camp Lejeune water, and treatment outcomes.
Our Bladder Cancer Settlement Amount Projections Might Be Low
We are assuming the government will offer a settlement amount less than the going rate for bladder cancer Camp Lejeune lawsuits. Because the average settlement value of a bladder cancer case is north of $300,00. I base that settlement amount projection on the Actos litigation, a piece of litigation 8 years ago where bladder cancer lawsuits settled for an average of about $300,000.
The true settlement amount for Camp Lejeune bladder cancer lawsuits should be higher for two reasons.
First, the defendant in the Actos lawsuits vigorously disputed liability. Here, the government presumptively assumes your bladder cancer is from Camp Lejeune.
There is also inflation. That same per person settlement of $300,000 is likely worth at least $350,000 per victim in 2022.
When Will the Camp Lejeune Justice Act of 2022 Become Law?
Our lawyers believe the PACT Act, which holds the Camp Lejeune Justice Act of 2022, will become law in late July 2022.
Verdicts and Settlements Involving Bladder Cancer
One way to project settlement amounts in Camp Lejeune bladder cancer lawsuits is to look at settlement amounts and jury payouts in lawsuits where the injury was bladder cancer.
- 2020, Pennsylvania: $325,000 Settlement. An 80-year-old man died from advanced bladder cancer. He was treated for hypertension for three years. During this period, a urinalysis revealed hematuria. However, the man was never informed of these results. He also underwent no additional cancer screenings or treatments. The man only received his bladder cancer diagnosis shortly before his death. His family alleged negligence against the physician. They claimed he failed to rule out cancer, appreciate his urinalysis, and provide suitable care. This case settled for $325,000.
- 2019, Pennsylvania: $8,000,000 Verdict. A 40-something man developed advanced bladder cancer. He underwent bladder and prostate removals. The man now required reconstructive procedures, chemotherapy, and radiation. Before his bladder cancer diagnosis, he was initially diagnosed with kidney stones and a suspicious bladder mass. The man received no additional treatments. He alleged that the treating D.O.’s failure to follow up on the bladder mass caused his cancer to advance. The jury awarded $8,000,000.
- 2017, Pennsylvania: $300,000 Verdict. A 53-year-old man died from severe bladder cancer. Before his diagnosis, he came under a urologist’s care for urinary problems. The man’s tests revealed suspicious results, including a slightly erythematous bladder and atypical cells that suggested cancer. He was diagnosed three years later. The man died four additional years later. His family alleged that the physician’s failure to follow up on suspicious tests caused the cancer to advance. This case settled for $300,000.
- 2015, Pennsylvania: $3,652,636 Verdict. A man was prescribed Actos. Six years later, he received a bladder cancer diagnosis. The man underwent bladder and tumor removals. He alleged failure to warn and defective design against Actos’ manufacturer, Takeda Pharmaceuticals. The jury awarded $3,652,636.
- 2015, West Virginia: $155,000 Verdict. A man took Actos for 18 months. He developed bladder cancer. The man alleged negligence against Actos’ manufacturer, Takeda Pharmaceuticals. He claimed it failed to warn the public, designed an unsafe drug, and failed to test it. The jury awarded $155,000.
- 2014, Pennsylvania: $2,050,000 Verdict. A woman was diagnosed with bladder cancer five years after taking Actos. She had several tumors surgically removed. The woman alleged breached warranties, defective design, and failure to warn against Takeda Pharmaceuticals. She received a $2,050,000.
Contact Us About a Camp Lejeune Bladder Cancer Lawsuit
If you (or a deceased family member) lived or worked at Camp Lejeune between 1953 and 1987 and you subsequently developed bladder cancer, call us today at 800-553-8082 to see if you have a compensation claim. You can also get a free, no-obligation case review online.